The Role of the Person Focused IARA Model in Reducing Anxiety and Improving Body Awareness and Illness Management in Diabetics with Acquired Lipodystrophy: A Mixed-Method Study

Author:

Viglino Francesca,Sellami MahaORCID,Broglio Fabio,Scuntero Paola,Padovan Anna Maria,Maulini Claudia,Beccuti GuglielmoORCID,Bragazzi NicolaORCID,Barattucci MassimilianoORCID,Kuvačić GoranORCID,De Giorgio AndreaORCID

Abstract

Background: Lipodystrophy is one of the most frequent complications in people with diabetes following subcutaneous insulin therapy, and poor management can lead to several problems, such as impaired glycemic control and adherence to therapy, anxiety, and depression. Poor injection technique represents the main risk factor for lipodystrophies. In order to enhance the patient’s insulin injection technique to heal lipodystrophy, improve psychological indices, and promote involvement in their health and care, the efficacy of emerging person-centered care called the IARA model was tested. Methods: A total of 49 patients were randomly allocated to the IARA group (Experimental; n = 25) or standard education (Control; n = 24). The following questionnaires were used in a mixed-method design: (i) State Anxiety Scale; (ii) Beck Depression Inventory; (iii) Italian Summary of Diabetes Self-Care Activities. An ad hoc open-ended questionnaire was structured for the qualitative analysis. Finally, photos were taken in order to verify if injection sites were changed until the follow-up at 12 months. The number of patients who participated until the completion of the study was 17 in the IARA and 11 in the Control group. Results: State anxiety was significantly reduced in people who followed IARA to follow-up at 3 and 6 months (p < 0.05). The IARA group also demonstrated better compliance in blood glucose monitoring and foot-care compared to Control at follow-up at 12 months. The management of insulin injections dramatically improved in participants who received IARA intervention. Conclusions: IARA could be considered an effective strategy to improve well-being and compliance in people affected with diabetes mellitus and lipodystrophy complications.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference66 articles.

1. (2022, October 10). Diabetes. Available online: https://www.who.int/health-topics/diabetes#tab=tab_1.

2. (2022, October 10). Diabete—Aspetti Epidemiologici. Available online: https://www.epicentro.iss.it/diabete/epidemiologia-italia.

3. Global trends in diabetes complications: A review of current evidence;Diabetologia,2019

4. (2022, September 03). World Health Organization Global Report on Diabetes. Available online: https://www.who.int/publications/i/item/9789241565257.

5. American Diabetes Association (2021). ADA Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes—2021. Diabetes Care, 44, S111–S124.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3